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ABSTRACT 
 Hydrazinolysis of ethyl-5-morpholin-4-yl-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinoline-2-carboxylate  
afforded the corresponding carbohydrazide which upon condensation with aromatic aldehydes, acetyl acetone and/ or 
carbon disulfide gave N- arylidinecarbohydrazide, dimethylpyrazolyl methanone, [1,3,4]oxadiazole-2-thiol and its ethyl 
ester derivatives respectively. Diazotization of the carbohydrazide with nitrous acid afforded the corresponding carboazide 
which was used for synthesis of carbamates and substituted carboxamides. Boiling of the carboazide in dry xylene 
afforded the pyrazinone compound which was used for synthesis of other heterocycles containing 
pyrrolopyrazinothinoisoquinoline moeity.  
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INTRODUCTION 
Isoquinoline alkaloids are a large family of natural products and display a broad variety of biological activities. 
1
 among the 
members of this class of compounds, tetrahydroisoquinoline derivatives constitute a major group. Many of them exhibit 
important biological activities, for example, anti-inflammatory, anti-microbial, anti-leukemic, and anti-tumor properties.
2,3
, 
anti-HIV, and other biological activities 
4-7
. Substituted tetrahydroquinolines are the core structures in many important 
pharmacological agents and drug molecules such as anti-arrhythmic and cardiovascular agents, anticancer drugs, 
immunosuppressants and as ligands for 5-HTIA and NMDA receptors
8-11
. Thienoquinolines are reported to exhibit a broad 
spectrum of biological effects. Some of them are useful as memory enhancers,
12
 antiallergics,
13
 anti-inflammatories, 
immunoregulators, analgesics and antipyritics.
14 
Others are known to possess a good antibacterial 
15
 and 
antianaphylactic
16 
activities.  
RESULTS AND DISCUSSION 
In continuation of our work about synthesis of heterocyclic compounds containing morpholinyl- tetrahydrothieno[2,3-
c]isoquinoline moiety as described in references 
17-21 
hoping these new compounds show biological activity. The authors 
incorporated pyrrolyl ring to the thienotetrahydroisoquinoline system through the reaction of ethyl-1-amino-5-morpholin-4-
yl-6,7,8,9-tetrahydrothino[2,3-c]isoquinole-2-carboxylate 1 with 2,5-dimethoxytetrahydrofuran in glacial acetic acid to afford 
the corresponding pyrrolyl ester 2. The structure of compound 2 was established by IR, 
1
H-NMR and mass spectra. IR 
spectrum showed disappearance of absorption bands characteristic for NH2 group and absorption band at 1720 cm
-1
 for 
ester group is still remaining. 
1
H-NMR in CDCl3 of compound 2 showed singlet signal characteristic for pyrrolyl group at 
6.30 and 6.70 ppm. Mass spectrum showed a peak at 411 as molecular ion peak and a base peak. Reaction of pyrrolyl 
ester 2 with hydrazine hydrate afforded the pyrrolyl carbohydrazide 3. The structure of 3 was elucidated by elemental and 
spectral analysis. IR spectrum showed absorption bands at 3400, 3500 and 3100 cm
-1
 characteristic for NH, NH2 groups 
and lowering the wave number of CO group in hydrazide from 1720 cm
-1
 in ester compound 2 to 1645 cm
-1
 in 
carbohydrazide 3. 
1
H-NMR spectrum in DMSO-d6 showed signals at, 5.80 and 4.70 for NH2, NH groups respectively. 
Mass spectrum showed at peak at 397 as molecular ion peak. 
 The pyrrolyl carbohydrazide 3 was used as versatile precursor for synthesis of other hetero cyclic system. Thus, 
condensation of the carbohydrazide 3 with aromatic aldehydes namely benzaldhyde, p-anisaldehyde and/ or 
cinnamaldehyde afforded the corresponding Schiff's bases (imines) (4a-c). IR spectrum of 4a revealed disappearance of 
absorption bands characteristic for NH2 group in hydrazide 3. 
1
H-NMR spectrum in DMSO-d6 showed multiplet signals at δ 
7.30-7.70 characteristic for aromatic protons and at 7.85 for CH benzylidene (scheme 1). 
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Condensation of carbohydrazide 3 with acetyl acetone afforded the dimethylpyrazolyl derivative 5. The structure of the 
latter compound was established by elemental and spectral analysis. IR spectrum showed disappearance of absorption 
bands characteristic for NH, NH2 group of carbohydrazide 3.
 1
H-NMR in CDCl3 showed two singlet signals at δ 2.30 and 
2.50 for two methyl groups of pyrazole and singlet signals at 5.95 ppm for CH pyrazole. Also reaction of compound 3 with 
carbon disulfide in dry pyridine gave the oxadiazole thione 6 which was alkylated using ethyl chloroacetate in presence of 
ethanol and fused sodium acetate to afford the ethyl sulfanyl acetate 7 (scheme 2).  
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Diazotization of carbohydrazide 3 with sodium nitrite in acetic acid at room temperature afforded the corresponding 
carboazide 8. The structure of carboazide 8 was proved by m.p., TLC and IR spectra. IR spectrum revealed 
disappearance of absorption bands for NH, NH2 and appearance of absorption band at 2150 cm
-1
 characteristic for azido 
group. The carboazide compound 8 reacted with various primary, secondary and tertiary alcohols namely: ethanol, 
methanol, isopropanol and tert-butanol to give the corresponding carbamates 9a-d. The structure of ethyl carbamate 9a 
showed absorption bands at 3230 and 1715 cm
-1
 characteristic for NH and CO carbamate respectively. 
1
H-NMR of ethyl 
carbamate 9 in CDCl3 showed triplet and quartet signals at δ 1.30 and 4.20 for ethyl ester group and singlet signal at δ 
9.30 for NH group. On the other hand, the carboazide 8 reacts with various cyclic secondary amines and/ or aromatic 
amines (primary and secondary) to afford the corresponding carboxamide derivatives 10a-f. The structure of phenyl urea 
derivative 10c was elucidated by elemental and spectral data. IR spectrum showed absorption bands at 3350, 3280 for 
2NH groups. 
1
H-NMR spectrum in DMSO-d6 showed multiplet signals at δ 8.70, 9.80 ppm characteristic for NHph and 
NHCO respectively (scheme 3).  
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The carboazide 8 undewent Curtius rearrangement upon boiling dry xylene to afford the corresponding 
pyrrolopyrazinothienoisoquinoline 11. The structure of the latter compound 11 was established by elemental and spectral 
analysis. IR spectrum revealed the disappearance of absorption band at 2150 cm
-1
 characteristic for azido group and 
appearance of absorption band at 3280 cm
-1
 for NH group. 
1
H-NMR in CF3CO2D showed three singlet signals at δ 6.20, 
6.50 and 7.00 ppm characteristic for the three CH pyrrolo groups.  
Chlorination of the pyrazino compound 11 with phosphorus oxychloride under reflux gave the corresponding chloro 
derivative 12, which underwent nucleophilic substitution reactions with primary amines such as aniline and/or hydrazine 
hydrate to afford the corresponding phenyl amino 13 and hydrazino 14 respectively. The structure of compounds 13, 14 
was proved by IR, 
1
H-NMR spectra. IR spectrum of compound 13 showed absorption band at 3400 cm
-1
 for NH group. 1H-
NMR spectrum in DMSO-d6 showed multiplet signals at δ 7.20-7.80 ppm characteristic for aromatic protons. While IR 
spectrum of hydrazine 14 showed absorption band at 3350, 3300 and 3250 for NH, NH2 groups. 
1
H-NMR of compound 14 
in CDCl3 showed singlet signals at δ 6.50 and δ 7.90 for NH2 and NH groups respectively. 
Reaction of hydrazino compound 14 with benzaldehyde afforded the corresponding  benzylidene-8-morpholin-4-yl-
9,10,11,12-tetrahydropyrrolo[1'',2'':4',5']pyrazino[2',3': 5,4]thieno[2,3-c]isoquinoline-4-ylhydrazide (15), whilst condensation 
of hydrazino compound 14 with triethyl orthoformate in refluxing acetic acid accompanied by loss of ethanol molecule 
afforded the corresponding triazolo derivative 16. The structure of compounds 15, 16 was established by IR, 
1
H-NMR 
spectra. IR spectrum of compound 15 revealed disappearance of absorption bands characteristic for NH, NH2 groups. 1H-
NMR in CF3CO2D showed multiplet signals at δ 7.20-7.85 ppm for aromatic protons, while IR spectrum of compound 16 
showed absorption band at 1640 cm
-1
 for C=N. 
1
H-NMR spectrum of compound 16 showed singlet signal at 8.30 for CH 
triazole (scheme 4).  
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Numbering of carbon atoms for compounds 2, 10a needed for 
13
C-NMR analysis are described in the following figure: 
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EXPERIMENTAL 
All melting points are uncorrected and measured on a Fisher-John apparatus. Elemental analyses were determined on an 
Elementar Analysensystem GmbH-VarioEL V.3 microanalyzer in the central lab of Assiut University. Their results were 
found to be in good agreement (±0.2%) with the calculated values. IR spectra were recorded on a Pye-Unicam Sp-100 
spectrophotometer using KBr wafer technique. NMR spectra were recorded on a varian EM-390 90 MHz and Joel 400 
MHz spectrometers in a suitable deutrated solvent using TMS as internal standard (chemical shifts in ppm).  MS spectra 
were recorded on Jeol JMS-600 apparatus. The amino ester compound 1 was prepared according to literature 
procedure
17
 with melting point 202-204
o
C.  
Ethyl-5-morpholin-4-yl-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c] isoquinoline-2-
carboxylate (2) 
A mixture of ethyl-1-amino-5-morpholin-4-yl-6,7,8,9-tetrahydrothieno[2,3-c]iso quinoline-2-carboxylate (1) (3.6 g, 0.01 mol) and 
2,5-dimethoxytetrahydrofuran (1.50 ml, 0.011 mol) in acetic acid (15 ml) was refluxed for 1 hr. The solid product which formed 
on cold was filtered off, dried and recrystallized from ethanol to give white needles in 83% yield, m.p. 186-188
o
C. Anal. Calcd. 
For: C22H25N3O3S (411.53): C, 64.21; H, 6.12; N, 10.21; S, 7.79%. Found: C, 64.25; H, 6.10; N, 10.16; S, 7.83%. IR ν (cm
-1
): 
2950, 2850 (CH aliphatic), 1720 (CO ester), 1620 (C=N). 
1
H-NMR (CDCl3): 1.10-1.30 (t, J= 9.00 Hz, 3H, CH3 ester), 1.70 (m, 
4H, 2CH2 cyclohexeno), 2.65 (m, 4H, 2CH2 cyclohexeno), 3.35 (m, 4H, 2 x CH2-N morpholine), 3.80 (m, 4H, 2 x CH2-O 
morpholine), 4.05-4.30 (q, J= 7.50 Hz, 2H, CH2 ester), 6.30 (s, 2H, 2CH=C pyrrolyl), 6.70 (s, 2H, 2CH-N pyrrolyl). 
13
C-NMR 
(CDCl3, 400 MHz): 13.91 (C18, CH3 ester), 22.03, 22.27, 22.32, 26.45 (C19-C22 cyclohexeno), 50.10 (C13: C16, (CH2)2-N 
morpholino), 61.29 (C17, CH2 ester), 66.96 (C14:C15, (CH2)2-O morpholino), 109.15 (C11, C12 pyrrolyl), 122 (C7, C10 
pyrrolyl), 124.90 (C2), 136.79 (C5), 144.96 (C1, C4), 156.03 (C3), 161 (C9), 161.64 (C6, CO ester). EI-MS: m/z (%) = 411 (M
+
, 
100), 381 (M
+
-Et, 11), 366 (M
+
-OEt, 10), 354 (M
+
-COEt, 22), 325 (M
+
-morpholino, 4), 86 (morpholino, 3). 
5-Morpholin-4-yl-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]iso- quinoline-2-carbo 
hydrazide (3) 
A mixture of pyrrol-1-yl ester compound 2 (1 g, 2.5 mmol) and hydrazine hydrate (5 ml, 0.1 mol) was heated under neat 
conditions for 1 hr then ethanol absolute (10 ml) was added and reflux continued for additional 2 hrs. The solid product which 
formed on cold was filtered off, dried and recrystallized from ethanol to afford white crystals in 69% yield, m.p. 236-238
o
C. 
Anal. Calcd. For: C20H23N5O2S (397.50) C, 60.43; H, 5.83; N, 17.62; S, 8.07%. Found: C, 60.40; H, 5.79; N, 17.65; S, 8.00%.  
IR ν (cm
-1
): 3400, 3300, 3100 (NH, NH2), 2950, 2850 (CH aliphatic), 1645 (CO hydrazide), 1620 (C=N). 
1
H-NMR (DMSO-d6): 
1.50 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N morpholine), 3.70 (m, 4H, 2 x 
CH2-O morpholine), 5.80 (S, 2H, NH2), 6.30 (s, 2H, 2CH=C pyrrrolyl), 6.95 (s, 2H, 2CH-N pyrrolyl), 7.40 (s, 1H, NH). EI-MS: 
m/z (%) = 398 (M
+
+1, 20.1), 397 (M
+
, 34), 396 (M
+
-1, 30), 368 (22), 366 (M
+
-N2H3, 100), 361 (21), 353 (M
+
-CONH2, 14), 297 
(M
+
-C4H8N2O, 21), 281 (17), 253 (23), 225 (16).   
N-Arylidene-1-(1H-pyrrol-1-yl)-5-morpholin-4-yl--6,7,8,9-tetrahydrothieno [2,3-
c]isoquinoline-2-carbohydraide (4) 
General procedure: 
Carbohydrazide compound 3 (0.5 g, 2 mmol) and aromatic aldehyde (2.5 mmol) were refluxed in ethanol (20 ml) and acetic 
acid (0.5 ml) for 2 hrs. The solid precipitate which is formed during reflux was filtered off, dried and recrystallized from the 
proper solvent. 
N-Benzylidene-1-(1H-pyrrol-1-yl)-5-morpholin-4-yl--6,7,8,9-tetrahydrothieno[2,3-c]isoquinoline-2-
carbohydraide (4a) 
Obtained from carbohydrazide 3 and benzaldehyde. The solid precipitate which is formed during reflux was filtered off, 
dried and recrystallized from acetic acid as white crystals. IR ν (cm
-1
): 3300 (NH), 3050 (CH aromatic), 2950, 2850 (CH 
aliphatic), 1650 (CO hydrazide), 1610 (C=N). 
1
H-NMR (DMSO-d6): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 2.80 (m, 4H, 2 x 
CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N morpholine), 3.80 (m, 4H, 2 x CH2-O morphoine), 6.50 (s, 2H, 2 CH=C pyrrolyl), 
6.95 (s, 2H, 2CH-N pyrrolyl), 7.30-7.70 (m, 5H,  ArH), 7.85 (s, 1H, N=CHph), 8.00 (s, 1H, NH). 
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Table 1: Physical constants of compounds 4a-c, 9a-d, 10a-g 
Yield Mp, 
o
C 
Found, % 
Calculated, % 
Empirical 
Formula 
compound 
S N H C 
0.44 g 
(72%) 
260-262 
6.67 
6.60 
14.38 
14.42 
5.65 
5.60 
66.72 
66.78 
C27H27N5O2S 
(485.61) 
4a 
0.52 g 
(80%) 
 
268-270 
6.28 
6.22 
13.64 
13.58 
5.71 
5.67 
65.10 
65.22 
C28H29N5O3S 
(515.64) 
4b 
0.49 g 
(76%) 
280-282 
6.33 
6.27 
13.75 
13.69 
5.80 
5.71 
67.94 
68.08 
C29H29N5O2S 
(511.62) 
4c 
0.43 g 
(83%) 
232-234 
7.58 
7.52 
13.24 
13.14 
6.22 
6.14 
62.00 
61.95 
C22H26N4O3S 9a 
0.4 g (80%) 210-212 
7.85 
7.77 
13.64 
13.58 
5.90 
5.86 
61.05 
61.15 
C21H24N4O3S 9b 
0.46 g 
(86%) 
216-218 
7.40 
7.28 
12.68 
12.72 
6.50 
6.41 
62.76 
62.70 
C23H28N4O3S 9c 
0.42 g 
(76%) 
226-228 
6.96 
7.05 
12.25 
12.32 
6.54 
6.65 
63.48 
63.41 
C24H30N4O3S 9d 
0.39 g 
(68%) 
208-210 
6.92 
6.86 
15.10 
14.98 
6.00 
6.25 
61.57 
61.65 
C24H29N5O3S 10a 
0.34 g 
(60%) 
224-226 
7.00 
6.86 
17.92 
18.01 
6.54 
6.48 
61.82 
61.78 
C24H30N6O2S 10b 
0.37 g 
(64%) 
220-222 
7.00 
6.89 
 
14.97 
15.04 
6.66 
6.71 
64.56 
64.49 
C25H31N5O2S 10c 
0.42 g 
(70%) 
218-220 
6.70 
6.77 
14.85 
14.79 
5.62 
5.75 
66.00 
65.94 
C26H27N5O2S 10d 
0.48 g 
(80%) 
230-232 
6.48 
6.58 
14.47 
14.36 
6.08 
5.99 
66.62 
66.51 
C27H29N5O2S 10e 
0.44 g 
(65%) 
234-236 
 
11.73 
11.60 
 
15.15 
15.21 
5.20 
5.11 
56.61 
56.50 
C26H28N6O4S2 10f 
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N-(4-Methoxybenzylidene-1-(1H-pyrrol-1-yl)-5-morpholin-4-yl--6,7,8,9-tetra hydrothieno[2,3-
c]isoquinoline-2-carbohydraide (4b) 
Obtained from carbohydrazide 3 and p-.anisaldehyde. The solid precipitate which is formed during reflux was filtered off, 
dried and recrystallized from acetic acid as white crystals. IR ν (cm
-1
): 3280 (NH), 3030 (CH aromatic), 2950, 2850 (CH 
aliphatic), 1645 (CO hydrazide), 1600 (C=N). 
1
H-NMR (CF3CO2D): 1.95 (m, 4H, 2 x CH2 cyclohexeno), 2.90 (m, 4H, 2 x 
CH2 cyclohexeno), 3.90 (m, 4H, 2 x CH2-N morpholine), 4.25 (s, 3H, OCH3), 4.50 (m, 4H, 2 x CH2-O morpholine), 6.95 (s, 
2H, 2CH=C pyrrolyl), 7.30 (s, 2H, 2CH-N pyrrolyl), 7.70-8.00 (m. 5H, ArH), 8.25 (s, 1H, N=CH).  
2-Morholin-4-yl-N-(3-phenylallylidene)-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydro thieno[2,3-c] 
isoquinoline-2-carbohydrazide (4c) 
Obtained from carbohydrazide 3 and cinnamaldehyde. The solid precipitate which is formed during reflux was filtered off, 
dried and recrystallized from dioxane as yellow crystals. IR ν (cm-1): 3300 (NH), 3050 (CH aromatic), 1655 (CO), 1600 
(C=N). 
1
H-NMR (CF3CO2D): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 2.80 (m, 4H, 2 x CH2 cyclohexeno), 3.30 (m, 4H, 2 x CH2-
N morpholine), 3.90 (m, 4H, 2 x CH2-O morpholine), 6.30 (s, 2H, 2 x CH=C pyrrolyl), 6.90 (s, 2H, 2 x CH-N pyrrolyl), 7.20-
7.80 (m, 7H, ArH+ CH=CH), 8.30 (s, 1H, N=CH).   
(3,5-Dimethyl-1H-pyrazol-1-yl)(5-morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydro 
thieno[2,3-c]isoquinolin-2-yl)methanone (5) 
A mixture of carbohydrazide compound 3 (0.5 g, 1.2 mmol) and acetyl acetone (0.2 ml, 2 mmol) in ethanol (20 ml) was 
refluxed for 3 hrs. The solid product which formed during reflux was filtered off, dried and recrystallized from ethanol-
dioxane mixture in 79% yield, m.p. 178-180
o
C. Anal. Calcd. For: C25H27N5O2S (461.59) C, 65.05; H, 5.90; N, 15.17; S, 
6.95%. Found: C, 65.00; H, 6.00; N, 15.23; S, 7.00%. IR ν (cm
-1
): 3920, 2820 (CH aliphatic), 1695 (CO), 1620 (C=N). 
1
H-
NMR (CDCl3): 1.65 (m, 4H, 2 x CH2 cyclohexeno), 2.30, 2.50 (2s, 6H, 2 x CH3 pyrazole), 2.70 (m, 4H, 2 x CH2 
cyclohexeno), 3.25 (m, 4H,2 x CH2-N morpholine), 3.80 (m, 4H, 2 x CH2-O morpholine), 5.95 (s, 1H, CH pyrazole), 6.35 (s, 
2H, 2CH=C pyrrolyl), 6.80 (s, 2H, CH-N pyrrolyl). EI-MS: m/z (%) =462 (M
+
+1, 11), 461 (M
+
, 100), 446 (M
+
-CH3, 45), 431 
(M
+
-2CH3, 9.2), 397 (M
+
-C5H4, 11), 375 (M
+
-morpholino, 21.6), 366 (M+-C5H7N2, 4.6), 338 (M
+
-C6H7N2O, 15), 252 (M+-
C10H15N3O2, 9). 
5-(5-Morpholin-4-yl-1-pyrrol-1-yl-6,7,8,9-tetrahydrothieno[2,3-c]iso quinolin-2-yl)-
[1,3,4]oxadiazole-2-thiol (6) 
A mixture of carbohydrazide compound 3 (1.0 g, 1.20 mmol) and carbon disulfide (2 ml) in dry pyridine (4 ml) was heated 
on steam bath for 6 hrs. The solid product which formed during heating washed with ethanol, filtered off, dried and 
recrystallized from ethanol into pale yellow crystals in 81% yield, m.p. 312-314
o
C.  Anal. Calcd. For: C12H21N5O2S2 (439.56) 
C, 57.38; H, 4.82; N, 15.93; S, 14.59%. Found: C, 57.30; H, 4.86; N, 16.00; S, 14.64%. IR ν (cm
-1
): 2920, 2850 (CH 
aliphatic), 1600 (C=N). 
1
H-NMR (CF3CO2D): 2.00 (m, 4H, 2 x CH2 cyclohexeno), 2.80 (m, 4H, 2 x CH2 cyclohexeno), 3.65 
(m, 4H, 2 x CH2-N morpholine), 4.20 (m, 4H, 2 x CH2-O morpholine), 6.70 (s, 2H, 2CH=C pyrrolyl), 7.05 (s, 2H, 2CH-N 
pyrrolyl).  
Ethyl[5-(5-Morpholin-4-yl-1-pyrrol-1-yl-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl)-
[1,3,4]oxadiazol-2-ylsulfanyl] acetate (7) 
A mixture of thiol compound 6 (0.50 g, 1.13 mmol) and ethyl chloroacetate (0.2 ml, 1.6 mmol) in ethanol (20 ml) in 
presence of fused sodium acetate (0.3 g, 4 mmol) was refluxed for 2 hrs. The solid precipitate which formed on cooling 
and dilution with water was filtered off, dried and recrystallized from ethanol into white crystals in 76% yield, m.p. 224-
226
o
C. Anal. Calcd. For: C25H27N5O4S2 (525.65) C, 57.12; H, 5.18; N, 13.32; S, 12.20%. Found: C, 57.30; H, 5.38; N, 
13.08; S, 12.23%; IR ν (cm
-1
): 2950, 2850 (CH aliphatic), 1730 (CO ester), 1620 (C=N). 
1
H-NMR (CDCl3): 1.30 (t, J= 7.50 
Hz, 3H, CH3 ester), 1.70 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N 
morpholine), 3.80 (m, 4H, 2 x CH2-O morpholine), 4.10 (s, 2H, SCH2), 4.20 (q, J= 6.00 Hz, 2H, CH2 ester), 6.30 (s, 2H, 
2CH=C pyrrolyl), 6.90 (s, 2H, 2CH-N pyrrolyl).     
Morpholin-4-yl-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]iso quinoline-2-
carboazide (8) 
Sodium nitrite solution (0.30 g, 4.20 mmol, 10%) was added dropwise with stirring to a solution of carbohydrazide compound 3 
(0.50 g, 1.20 mmol) in glacial acetic acid (20 ml) at 0
o
C in an ice bath for 5 minutes. The solid product which formed during 
stirring was filtered off, dried and used without recrystallization in 56% yield, m.p. 140-142
o
C. Anal. Calcd. For: C20H20N6O2S 
(408.49) C, 58.81; H, 4.94; N, 20.57; S, 7.85%. IR ν (cm
-1
): 2950, 2850 (CH aliphatic), 2150 (N3), 1665 (CO azide), 1580 
(C=N). 
0.44 g 
(56%) 
238-240 
15.00 
15.13 
15.36 
15.42 
4.51 
4.60 
54.86 
54.79 
C29H29N7O4S3 10g 
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Alkyl-5-morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl 
carbamate (9 a-d) 
 General procedure: 
A solution of carboazide compound 8 (0.5 g, 1.2 mmol) in an alcohol (20 ml) was refluxed for 2 hrs. The solid product which 
formed during reflux was filtered off, dried and recrystallized from ethanol-dioxane 1:1. 
Ethyl-5-morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]iso quinolin-2-yl carbamate (9a) 
Obtained from carboazide 8 and ethanol. The solid product was recrystallized from ethanol-dioxane 1:1 mixture as white 
crystals. IR ν (cm
-1
): 3230 (NH), 2920, 2820 (CH aliphatic), 1715 (CO carbamate), 1590 (C=N). 
1
H-NMR (CDCl3): 1.30 (t, J= 
7.5 Hz, 3H, CH3), 1.70 (m, 4H, 2 x CH2 cyclohexeno), 2.75 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N morpholine), 
3.80 (m, 4H, 2 x CH2-O morpholine), 4.20 (q, J= 6.0 Hz, 2H, CH2 ester), 6.30 (s, 2H, 2CH=C pyrrolyl), 6.90 (s, 2H, 2CH-N 
pyrrolyl), 9.30 (s, 1H, NH). 
Methyl-5-morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl carbamate (9b) 
Obtained from carboazide 8 and methanol. The solid product was recrystallized from ethanol as pale brown crystals. IR ν (cm
-
1
): 3200 (NH), 2920, 2850 (CH aliphatic), 1720 (CO ester), 1600 (C=N). 
1
H-NMR (CDCl3): 1.50 (m, 4H, 2 x CH2 cyclohexeno), 
2.60 (m, 4H, 2 x CH2 cyclohexeno), 3.00 (m, 4H, 2 x CH2-N morpholine), 3.70 (m, 4H, 2 x CH2-O morpholine), 6.25 (s, 2H, 
2CH=C pyrrolyl), 6.70 (s, 2H, 2CH-N pyrrolyl), 9.60 (s,1H, NH). 
Isopropyl-5-morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl carbamate (9c) 
Obtained from carboazide 8 and isopropanol. The solid product was recrystallized from ethanol-dioxane 1:1 mixture into pale 
red crystals. IR ν (cm
-1
): 3250 (NH), 2980, 29220, 2850 (CH aliphatic), 1715 (CO carbamate). 1H-NMR (CDCl3): 1.30,1.35 (d, 
6H, 2CH3 isopropyl), 1.70 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.15 (m, 4H, 2 x CH2-N 
morpholine), 3.80 (m, 4H, 2 x CH2-O morpholine), 5.00 (s, 1H, CH isopropyl), 6.30 (s, 2H, 2CH=C pyrrolyl), 6.70 (s, 2H, CH-N 
pyrrolyl), 9.55 (s, 1H, NH) . EI-MS: m/z (%) = 440 (M+, 100), 412 (M+-C2H4, 12), 397 (M
+
-C3H7, 15), 381 (M
+
-C3H7O, 3), 354 
(M
+
-C4H6O2, 21), 338 (M
+
-C4H8NO2). 
t-Butyl-(5-Morpholin-4-yl-1-pyrrol-1-yl-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl) carbamate (9d) 
Obtained by the reaction of carboazide 8 with tert-butanol. The solid product was recrystallized from ethanol-dioxane 1:1 
mixture into white crystals. IR ν (cm
-1
): 3300 (NH), 2920, 28510 (CH aliphatic), 1710 (CO carbamate), 1590 (C=N). 
1
H-NMR 
(CDCl3): 1.50 (s, 9H, 3CH3), 1.70 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.10 (m, 4H, 2 x CH2-N 
morpholine), 3.85 (m, 4H, 2 x CH2-O morpholine), 6.30 (s, 2H, 2CH=C pyrroyl), 6.70 (s, 2H, 2CH-N pyrrolyl), 9.60 (s, 1H, NH). 
N-(5-Morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]iso- quinolin-2-yl) 
substituted-4-carboxamide (10a-g) 
General procedure: 
A mixture of pyrrol-1-ylcarboazide 8 (0.5 g, 1.2 mmol) and primary (secondry) amine (1.25 mmol) was refluxed in dry toluene 
for 2 hrs. The solid product which formed on cooling was filtered off, dried and recrystallized from the proper solvent. 
N-(5-Morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl) morpholine-4-
carboxamide (10a) 
Obtained from carboazide 8 and morpholine. The solid product was recrystallized from ethanol as pale green crystals. IR ν 
(cm
-1
): 3400-3300 (br NH), 2920, 2850 (CH aliphatic), 1640 (CO amide). 
1
H-NMR (CDCl3): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 
2.75 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 8H, 4CH2-N morpholine), 3.90 (m, 8H, 4CH2-O morpholine), 6.30 (s, 2H, 2CH=C 
pyrrolyl), 6.75 (s, 2H, 2CH-N pyrrolyl), 9.50 (s, 1H, NH). 
13
C-NMR (CDCl3): 21.93, 22.27, 23.33, 26.45 (C16-C19 cyclohexeno), 
50.31 (C12, C15, C21, C24 :2 x (CH2)2-N morpholino), 66.52, 66.96 (C13, C14, C22, C23: 2 x (CH2)2-O morpholino), 109.69 
(C10, C11 pyrrolyl), 123 (C6, C9 pyrrolyl), 123.76 (C2), 129.87 (C5), 144.51 (C3, C4), 160.46 (C8), 161.30 (C20, CO). EI-MS: 
m/z (%) = 467.18 (M+, 10), 441 (100). 
N-(5-Morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl) piperazine-4-
carboxamide (10b) 
Obtained from carboazide 8 and piperazine. The solid product was recrystallized from ethanol as white crystals. IR ν (cm
-1
): 
3400, 3300 (2NH), 2920, 2850 (CH aliphatic), 1650 (CONH), 1580 (C=N). 
1
H-NMR (DMSO-d6): 1.90 (m, 4H, 2x CH2  
cyclohexeno), 2.60 (m, 4H, 2 x CH2 cyclohexeno), 2.90 (m, 4H, 2CH2-NH piperazine), 3.20 (m, 8H, (CH2)2-N piperazine + 
(CH2)2-N morpholine), 3.80 (m, 4H, (CH2)2-O morpholine), 6.70 (s, 2H, 2CH=C pyrrolyl), 6.95 (s, 2H, 2CH-N pyrrolyl),  7.40 (s, 
1H, NH piperazine), 9.40 (s, 1H, NH amide). 
N-(5-Morpholino-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl) piperidine-4-
carboxamide (10c) 
Obtained from carboazide 8 and piperidine. The solid product was recrystallized from ethanol as white crystals. IR ν (cm
-1
): 
3400 (NH), 2950, 2850 (CH aliphatic), 1630 (CO amide), 1560 (C=N). 
1
H-NMR (CDCl3): 1.50 (m, 4H, 2 x CH2 C2, C4 
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piperidine), 1.60 (m, 2H, CH2 C3 piperidine), 1.75 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 
4H, 2 x CH2-N morpholine), 3.40 (m, 4H, 2 x CH2 C1, C5 piperidine), 3.80 (m, 4H, 2 x CH2-O morpholine), 6.30 (s, 2H, 2CH=C 
pyrrolyl), 6.90 (s, 2H, 2CH-N pyrrolyl), 9.60 (s, 1H, NH). 
1-(5-Morpholin-4-yl-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin-2-yl)-3-phenylurea 
(10d) 
Obtained from carboazide 8 and aniline. The solid product was recrystallized from dioxane as white needles. IR ν (cm
-1
): 3350, 
3280 (2NH), 3030 (CH aromatic), 2920, 2850 (CH aliphatic), 1690 (CO), 1590 (C=N). 
1
H-NMR (DMSO-d6): 1.70 (m, 4H, 2 x 
CH2 cyclohexeno), 2.65 (m, 4H, 2 x CH2 cyclohexeno), 3.25 (m, 4H, 2 x CH2-N morpholine), 3.70 (m, 4H, 2 x CH2-O 
morpholine), 6.30 (s, 2H, 2 x CH=C pyrrolyl), 6.85 (s, 2H, 2 x CH-N pyrrolyl), 7.30-7.70 (m, 5H, ArH), 8.70 (s, 1H, NHph), 9.80 
(s, 1H, NHCO).  
1-Benzyl-3-(5-morpholin-4-yl-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]iso quinolin-2-yl)urea 
(10e) 
Obtained from carboazide 8 and benzyl amine. The solid product was recrystallized from ethanol-dioxane 1:1 mixture as 
yellow needles. IR ν (cm
-1
): 3400, 3300 (2NH), 3020 (CH aliphatic), 2920, 2850 (CH aliphatic), 1630 (CO). 
1
H-NMR (CDCl3): 
1.70 (m, 4H, 2 x CH2cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N morpholine ), 3.90(m, 4H, 2 x 
CH2-O morpholine), 4.30 (s, 2H, CH2ph), 6.30 (s, 2H, 2 x CH=C pyrrolyl), 6.80 (s, 2H, 2 x CH-N pyrrolyl), 7.10-7.40 (m, 5H, 
ArH), 8.00 (s, 1H, NH benzyl), 9.60 (s, 1H, NHCO). 
4-(3-(5-Morpholin-4-yl-1-(1H-pyrrol-1-yl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinolin -2-yl) 
ureido)benzenesulfonamide (10f) 
Obtained from carboazide 8 and sulfanilamide. The solid product was recrystallized from dioxane as pale brown needles. IR ν 
(cm
-1
): 3400, 3350, 3250 (NH, NH2), 3030 (CH aromatic), 2920, 2850 (CH aliphatic), 1695 (CO). 
1
H-NMR (DMSO-d6): 1.70 (m, 
4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N morpholine), 3.80 (m, 4H, 2 x CH2-O 
morpholine), 5.90 (s, 2H, NH2), 6.20 (s, 2H, 2 x CH=C pyrrolyl), 6.80 (s, 2H, 2 x CH-N pyrrolyl), 8.85 (s, 1H, NHph), 9.60 (s, 
1H, CONH).  
4-(3-(5-Morpholin-4-yl)-1-(1H-pyrrol-1-yl)-6,7,8,9-tetragydrothieno[2,3-c]isoquinolin -2-yl)ureido)-N-
(thiazol-2-yl)benzenesulfanamide (10g) 
Obtained from carboazide 8 and sulfathiazole. The solid product was recrystallized from dioxane as white crystals. IR ν (cm
-1
): 
3400, 3350, 3250 (3NH), 3030 (CH aromatic), 2920, 2850 (CH aliphatic), 1705 (CONH). 
1
H-NMR (DMSO-d6): 1.70 (m, 4H, 2 x 
CH2 cyclohexeno), 2.60 (m,4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N morpholine), 3.85 (m, 4H, 2 x CH2-O 
morpholine), 6.30 (s, 2H, 2 x CH=C pyrrolyl), 6.70 (s, 2H, 2CH-N pyrrolyl), 7.20-7.80 (m, ,6H, ArH+ 2CH thiazole), 8.90 
(NHph), 9.60 (NHCO), 10.60 (s, 1H, NH thiazole). 
8-Morpholin-4-yl-9,10,11,12-tetrahydropyrrolo[1'',2'':4',5']pyrazino[2',3' :5,4] 
thieno[2,3-c] isoquinolin-4(5H)-one (11) 
A suspension of caboazide compound 8 (1 g, 2.45 mmol) in xylene (5 ml) was refluxed for 2 hrs. The solid product which 
formed during reflux was filtered off, dried and recrystallized from dioxane into white crystals in 38% yield, m.p. 320-
322
o
C. Anal. Calcd. For: C20H20N4O2S (380.47) C, 63.14; H, 5.30; N, 14.73; S, 8.43%. Found: C, 63.22; H, 5.38; N, 14.86; 
S, 8.50%. IR ν (cm
-1
): 3280 (NH), 2920, 2850 (CH aliphatic), 1640 (CO pyrazine), 1585 (C=N). 
1
H-NMR (CF3CO2D): 1.80 
(m, 4H, 2 x CH2 cyclohexeno), 2.50 (m, 4H, 2 x CH2 cyclohexeno), 3.65 (m, 4H, 2CH2-N morpholine), 4.20 (m, 4H, 2 x 
CH2-O morpholine), 6.20 (s, 1H, CH C:2 pyrrole), 6.50 (s, 1H, CH C:1 pyrrole), 7.30 (s, 1H, CH C:3 pyrrole). 
4-Chloro-8-morpholin-4-yl-9,10,11,12-tetrahydropyrrolo[1'',2'':4',5'] 
pyrazino[2',3':5,4]thieno[2,3-c]isoquinoline (12) 
A solution of pyrrolopyrazinothienoisoquinolinone 11 (1.00 g, 2.50 mmol) in phosphorus oxychloride (3 ml) was refluxed for 
2 hrs. The solid precipitate which formed on cooling and dilution with water was fi ltered off, dried and recrystallized from 
ethanol into green crystals in 60%, m.p. 116-118
o
C. Anal. Calcd. For: C20H19ClN4OS (398.92) C, 60.22; H, 4.80; N, 14.04; 
S, 8.04%. Found: C, 60.30; H, 5.00; N, 13.92; S, 8.15%. IR ν (cm
-1
): 2920, 2850 (CH aliphatic), 1620 (C=N). 
1
H-NMR 
(CDCl3): 1.70 (m, 4H, 2 x CH2 cyclohexeno), 2.60 (m, 4H, 2 x CH2 cyclohexeno), 3.25 (m, 4H, 2 x CH2-N morpholine), 
3.80 (m, 4H, 2 x CH2-O morpholine), 6.35 (s, 1H, CH C:2 pyrrole), 6.90 (s, 1H, CH C:3 pyrrole), 7.20 (s, 1H, CH C:1 
pyrrole). 
4-Phenylamino-8-morpholin-4-yl-9,10,11,12-tetrahydropyrrolo[1'',2'' 
:4',5']pyrazino[2',3':5,4]thieno[2,3-c]isoquinoline (13) 
A mixture of chloro compound 12 (0.5 g, 1.26 mmol) and aniline (0.25 ml, 2.70 mmol) was heated under neat conditions 
for 5 minutes then ethanol (15 ml) was added and reflux was continued for additional 2 hrs. The solid product which 
formed on cooling was filtered off, dried and recrystallized from ethanol: dioxane mixture into white crystals in 74% yield, 
m.p. 262-264
o
C. Anal. Calcd. For: C26H25N5OS (455.59) C, 68.55; H, 5.53; N, 15.37; S, 7.04%. Found: C, 68.60; H, 5.48; 
N, 15.44; S, 7.20%.  IR ν (cm
-1
): 3400 (NH), 3030 (CH aromatic) 2920, 2850 (CH aliphatic), 1595 (C=N). 
1
H-NMR (DMSO-
d6): 1.70 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.20 (m, 4H, 2 x CH2-N morpholine), 3.80 (m, 
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4H, 2x CH2-O morpholine), 6.35 (s, 1H, CH C:2 pyrrole), 6.90 (s, 1H, CH C:3 pyrrole), 7.20-7.80 (m, 6H, ArH+ CH C:1 
pyrrole), 9.70 (s, 1H, NH). 
4-Hydrazino-8-morpholin-4-yl-9,10,11,12-tetrahydropyrrolo[1'',2'':4',5'] 
pyrazino[2',3':5,4]thieno[2,3-c]isoquinoline (14) 
A solution of chloro compound (13) (0.50 g, 1 mmol) and hydrazine hydrate (0.25 g, 5 mmol) in ethanol was refluxed for 2 
hrs. The solid product formed on cooling was filtered off, dried and recrystallized from ethanol into white crystals in 52% 
yield, m.p. 242-244
o
C. Anal. Calcd. For: C20H22N6OS (394.50) C, 60.89; H, 5.62; N, 21.30; S, 8.13%. Found: C, 60.97; H, 
5.58; N, 21.38; S, 8.25%. IR ν (cm-1): 3350, 3300, 3250 (NH, NH2), 2920, 2850 (CH aliphatic), 1640 (C=N). 
1
H-NMR 
(CDCl3): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 2.70 (m, 4H, 2 x CH2 cyclohexeno), 3.25 (m, 4H, 2 x CH2-N morpholine), 
3.85 (m, 4H, 2 x CH2-O morpholine), 6.35 (s, 1H, CH C:2 pyrrole), 6.50 (s, 2H, NH2), 6.85 (s, 1H, CH C:3 pyrrole), 7.20 (s, 
1H, CH C:1 pyrrole), 7.90 (s, 1H, NH). 
Benzylidene-8-morpholin-4-yl-9,10,11,12-tetrahydropyrrolo[1'',2'':4',5'] 
pyrazino[2',3':5,4]thieno[2,3-c]isoquinoline-4-ylhydrazide (15) 
A mixture of hydrazine compound 14 (0.50 g, 1.27 mmol) and benzaldehyde (0.5 ml, 4.7 mmol) was heated under neat 
conditions for 5 minutes then ethanol (10 ml) was added and reflux was continued for 2 hrs. The solid product formed on 
cooling was filtered off, dried and recrystallized from ethanol: dioxane mixture as yellow crystals in 75% yield. Anal. Calcd. 
For: C27H26N6OS (482.61) C, 67.20; H, 5.43; N, 17.41; S, 6.64%. Found: C, 67.12; H, 5.50; N, 17.26; S, 6.85. IR ν (cm
-1
): 
3030 (CH aromatic), 1640 (C=N). 
1
H-NMR (CF3CO2D): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 2.75 (m, 4H, 2 x CH2 
cyclohexeno), 3.20 (m, 4H, 2 xCH2-N morpholine), 3.85 (m, 4H, 2 x CH2-O morpholine), 6.35 (s, 1H, CH C:2 pyrrole), 6.95 
(s, 1H, CH C:3 pyrrole), 7.20-7.80 (m, 7H, ArH + CHph + CH C:1 pyrrole). 
10-Morpholin-4-yl-11,12,13,14-tetrahydro[1,2,4]triazolo[3''',4''':6',1'] 
pyrrolo[1'',2'':4',5']pyrazino[2',3':5,4]thieno[2,3-c]isoquinoline (16) 
A mixture of hydrazino compound 15 (0.5 g, 1 mmol) and triethylortho formate (2 ml) in presence of glacial acetic acid (0.5 
ml) was refluxed for 2 hrs. The solid product which formed during reflux was filtered off, dried and recrystallized from 
ethanol: dioxane mixture as white crystals in 74% yield, m.p. 332-334
o
C. Anal. Calcd. For: C21H20N6OS (404.50) C, 62.36; 
H, 4.98; N, 20.78; S, 7.93%. Found: C, 62.45; H, 5.10; N, 20.63; S, 8.10%. IR ν (cm
-1
): 2950, 2850 (CH aliphatic), 1640 
(C=N). 
1
H-NMR (CF3CO2D): 1.80 (m, 4H, 2 x CH2 cyclohexeno), 2.75 (m, 4H, 2 x CH2 cyclohexeno), 3.30 (m, 4H, 2 x 
CH2-N morpholine), 3.95 (m, 4H, 2 x CH2-O morpholine), 6.35 (s, 1H, CH C:2 pyrrole), 6.90 (s, 1H, CH C:3 pyrrole), 7.20 
(s, 1H, CH C:1 pyrrole), 8.30 (s, 1H, CH triazole).    
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